Inclusion Criteria:

- Histologically confirmed primary cancer of the uterine cervix, uterine corpus, ovary,
and fallopian tube

- FIGO stage Cervical cancer: FIOG stage IA2-IIA2 Uterine cancer: FIGO stage I-III
Ovarian and fallopian tubal cancer: FIGO stage I-IIIB

- Patients who undergoing surgery including pelvic and/or para-aortic lymph node
dissection

- Patients with adequate bone marrow, renal and hepatic function:

WBC > 3,000 cells/mcl Platelets >100,000/mcl Creatinine <2.0 mg/dL Bilirubin <1.5 x normal
and SGOT or SGPT <3 x normal

- American Society of Anesthesiology Physical Status 0-1

- Performance status of ECOG 0-2

- Patient must be suitable candidates for surgery

- Patients who have signed an approved Informed Consent

Exclusion Criteria:

- Patients with a history of pelvic or abdominal radiotherapy;

- Patients who are pregnant

- Patients with contraindications to surgery;

- Patients who are unfit for Surgery: serious concomitant systemic disorders
incompatible with the study (at the discretion of the investigator);

- Patient's compliance and geographic proximity that do not allow adequate follow-up.

- Patients who undergo only lymph node sampling